Alzheimer's disease and coffee: a quantitative review
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis Ltd in Neurological Research
- Vol. 29 (1), 91-95
- https://doi.org/10.1179/174313206x152546
Abstract
To estimate the pooled risk of coffee consumption for Alzheimer's disease (AD). We have reviewed all observational studies that evaluated the association between AD risk and coffee consumption. Four studies were identified: two case-control studies and two cohorts. These studies were carried out between 1990 and 2002. There was an obvious protective effect of coffee consumption in the pooled estimate [risk estimate: 0.73 (95% confidence interval: 0.58-0.92)]. However, the homogeneity test was highly significant (p<0.01), indicating heterogeneity across the pooled studies. Pooled analysis applying the random effect model was 0.79 with 95% confidence interval overlapping unity (95% confidence interval: 0.46-1.36). Three studies assessed coffee consumption by interview questionnaire. The risk of AD in coffee consumers versus non-consumers in studies that used interview questionnaire had a pooled risk estimate of 0.70 with 95% confidence interval 0.55-0.90. Although our pooled estimates show that coffee consumption is inversely associated with the risk of AD, the four studies had heterogeneous methodologies and results. Further prospective studies evaluating the association between coffee consumption and AD are strongly needed.Keywords
This publication has 27 references indexed in Scilit:
- Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicityBritish Journal of Pharmacology, 2003
- Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and AgingAmerican Journal of Epidemiology, 2002
- Does caffeine intake protect from Alzheimer's disease?European Journal of Neurology, 2002
- Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, CanadaInternational Journal of Epidemiology, 2001
- Adenosine: does it have a neuroprotective role after all?Brain Research Reviews, 2000
- Rates and risk factors for dementia and Alzheimer’s diseaseNeurology, 1999
- Alzheimer's disease: a review of the disease, its epidemiology and economic impactArchives of Gerontology and Geriatrics, 1998
- Incidence and Risk of Dementia: The Rotterdam studyAmerican Journal of Epidemiology, 1998
- Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: Inconclusive results from a population-based cohort studyJournal of Clinical Epidemiology, 1996
- Risk factors for Alzheimer's diseaseNeurology, 1987